HLA-DR expression in clinical-grade bone marrow-derived multipotent mesenchymal stromal cells: a two-site study

BACKGROUND: Contrary to the minimal criteria proposed by the International Society for Cell and Gene Therapy for defining multipotent mesenchymal stromal cells (MSC), human leukocyte antigen (HLA)-DR expression is largely unpredictable in ex vivo-expanded clinical-grade cultures. Although activation...

Descripción completa

Detalles Bibliográficos
Autores principales: Grau-Vorster, Marta, Laitinen, Anita, Nystedt, Johanna, Vives, Joaquim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567533/
https://www.ncbi.nlm.nih.gov/pubmed/31196185
http://dx.doi.org/10.1186/s13287-019-1279-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567533/
https://www.ncbi.nlm.nih.gov/pubmed/31196185
http://dx.doi.org/10.1186/s13287-019-1279-9

Ejemplares similares